Changes

no edit summary
Line 1,910: Line 1,910:  
|
 
|
 
|
 
|
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
 
|IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
 
|Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG
 
|Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG
 
| ||
 
| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG
 
|Immunoglobulin-related (AL) amyloidosis||Disease|| || || || || ||SG
 
| ||
 
| ||
|
+
|Primary Amyloidosis
 
|Heather E. Williams, PhD, MS, PgD, ErCLG
 
|Heather E. Williams, PhD, MS, PgD, ErCLG
|
+
|?PENDING<br />
 
|
 
|
 
|
 
|
Line 1,948: Line 1,948:  
|Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG
 
|Monoclonal immunoglobulin deposition disease||Disease|| || || || || ||SG
 
| ||
 
| ||
|
+
|Light Chain and Heavy Chain Deposition Disease
 
|Chen Yang, MD, PhD, University of Michigan
 
|Chen Yang, MD, PhD, University of Michigan
|
+
|Complete
|
+
|10/15/2022
 
|
 
|
 
|-
 
|-
 
|Mu heavy chain disease||Disease|| || || || || ||SG
 
|Mu heavy chain disease||Disease|| || || || || ||SG
 
| ||
 
| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Gamma heavy chain disease||Disease|| || || || || ||SG
 
|Gamma heavy chain disease||Disease|| || || || || ||SG
 
| ||
 
| ||
|
+
|Gamma Heavy Chain Disease
 
|Manisha Brahmbhatt-Sutariya  Asst. Professor, Dept. of Pathology and Human Anatomy  Technical Supervisor, Clinical Genetics Laboratory  Loma Linda University, Medical Center, CA
 
|Manisha Brahmbhatt-Sutariya  Asst. Professor, Dept. of Pathology and Human Anatomy  Technical Supervisor, Clinical Genetics Laboratory  Loma Linda University, Medical Center, CA
|
+
|Complete
|
+
|5/26/2021
 
|
 
|
 
|-
 
|-
 
|Alpha heavy chain disease||Disease|| || || || || ||SG
 
|Alpha heavy chain disease||Disease|| || || || || ||SG
 
| ||
 
| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
|Plasmacytoma||Disease|| || || || || ||SG
+
|Plasmacytoma||Disease|| || || || ||author needs to include Solitary plasmacytoma of bone, Extraosseous plasmacytoma (extramedullary) (v4 page did not have content on ccga)
 +
|SG
 
| ||
 
| ||
|
+
|NEW (No Prior) - no content on version 4 page "Plasmacytoma' originally assigned to Zhenya Tang
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
|Plasma cell myeloma / multiple myeloma||Disease|| || || || || ||SG
+
|Plasma cell myeloma / multiple myeloma||Disease|| || || || ||Note: author needs to include Plasma_Cell_Myeloma_Variants content in this page||SG
 
| ||
 
| ||
|
+
|(1) Plasma Cell Myeloma + (2) Plasma Cell Myeloma Variants
|*Huan Mo, MD, MS *Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas
+
|(1) Huan Mo, MD, MS and Zhenya Tang, MD, PhD  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas + (2) Fariborz Rashid-Kolvear, PhD, FACMG, FCCMG
|
+
|Pending
 
|
 
|
 
|
 
|